SOUTHWELL DAVID P
The estimated Net Worth of SOUTHWELL DAVID P is at least $2 Million dollars dollars as of 05/29/2022. SOUTHWELL DAVID P is the Director of Rocket Pharmaceuticals Inc. SOUTHWELL DAVID P owns over 95,160 shares of Rocket Pharmaceuticals Inc stock worth over $1 Million dollars . SOUTHWELL DAVID P is the Director of PTC Therapeutics Inc. SOUTHWELL DAVID P owns over 1,650 shares of PTC Therapeutics Inc stock worth over $50,077.50. SOUTHWELL DAVID P is the Director of First Eagle Alternative Capital BDC Inc. SOUTHWELL DAVID P owns over 38,500 shares of First Eagle Alternative Capital BDC Inc stock worth over $149,380.00. SOUTHWELL DAVID P is the CEO of TScan Therapeutics Inc. SOUTHWELL DAVID P owns over 171,569 shares of TScan Therapeutics Inc stock worth over $542,158.04.
Insider Roles
| Name | Transaction Date | Position |
|---|---|---|
| PTC Therapeutics Inc | 2017-01-03 | director |
| Rocket Pharmaceuticals Inc | 2016-03-22 | director, officer: See Remarks |
| Spero Therapeutics Inc | 2018-02-01 | director |
| First Eagle Alternative Capital BDC Inc | 2010-11-16 | director |
| TScan Therapeutics Inc | 2021-07-15 | director, officer: Chief Executive Officer |
SOUTHWELL DAVID P trading performance
Average Relative Return
6.03%
Outperforming Transactions
33%
SOUTHWELL DAVID P trading performance analysis
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 1.7 | 3.55 | 1.37 | 6.03 | 30.98 | 61.37 |
| Relative Return to S&P 500(%) | -2.92 | -5.34 | -8.83 | 2.47 | 14.7 | 12.51 |
Southwell David P trading transactions
- 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.
SOUTHWELL DAVID P personal network
| Name | Position | Linked company |
|---|
